Teva just invested $3.2 billion in a California drug company that only does deuterated drugs. It purchases for $3.2 billion a company with almost no revenues. These are the sorts of life science industries in the United States and why they're so powerful, yet this investment is based on the availability of material, and we don't see how they're going to get raw materials.
Big industries and pharmaceuticals are making very large investments to globally manufacture and distribute deuterated drugs. Again, our technology, which is independent of government energy policy and government financing, is a completely new idea and is needed for this commercial success.